Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
155 GBX | +3.33% | +6.90% | -49.18% |
May. 03 | Kelso raises stake in NCC; Transense joins project | AN |
Apr. 30 | Faron Pharmaceuticals Ltd. Announces Appointment of Dr. Juho Jalkanen as Director | CI |
Sales 2024 * | 14.4M 15.48M | Sales 2025 * | 39.09M 42.02M | Capitalization | 130M 140M |
---|---|---|---|---|---|
Net income 2024 * | -6M -6.45M | Net income 2025 * | -4M -4.3M | EV / Sales 2024 * | 11.1 x |
Net Debt 2024 * | 30.6M 32.89M | Net cash position 2025 * | 42.27M 45.43M | EV / Sales 2025 * | 2.24 x |
P/E ratio 2024 * |
-5.88
x | P/E ratio 2025 * |
-11.6
x | Employees | 34 |
Yield 2024 * |
0.83% | Yield 2025 * |
-
| Free-Float | 60.17% |
Latest transcript on Faron Pharmaceuticals Oy
1 day | +3.33% | ||
1 week | +6.90% | ||
Current month | +6.90% | ||
1 month | +16.98% | ||
3 months | -45.99% | ||
6 months | -40.38% | ||
Current year | -49.18% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 02-12-31 | |
Founder | 46 | 02-12-31 | |
Founder | 70 | 02-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 70 | 02-12-31 | |
Chairman | 60 | 23-03-23 | |
Founder | 46 | 02-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 155 | +3.33% | 2,275 |
24-05-03 | 150 | 0.00% | 8,165 |
24-05-02 | 150 | 0.00% | 4,213 |
24-05-01 | 150 | +3.45% | 1,565 |
24-04-30 | 145 | +3.57% | 21,598 |
Delayed Quote London S.E., May 07, 2024 at 11:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-49.18% | 136M | |
+10.44% | 106B | |
+0.82% | 104B | |
+6.72% | 23.25B | |
-13.89% | 22.5B | |
-6.64% | 18.7B | |
-37.26% | 17.95B | |
-10.98% | 16.99B | |
+8.67% | 14.26B | |
+41.08% | 12.76B |
- Stock Market
- Equities
- FARN Stock